Navigation Links
Panacea Biotec In-Licenses FMD Vaccine

Panacea Biotec Ltd today said it has entered into an agreement with the National Research Development Corporation (NRDC) // for in-licensing of Foot and Mouth Disease (FMD) vaccine developed by the Indian Veterinary Research Institute.

'As part of the agreement, we will produce and market the vaccine in the Indian market first. As and when we meet the requirements of the domestic market and if there is extra capacity available we will also export it,' company's Joint Managing Director Rajesh Jain said.

He said the vaccine would be rolled out in the market in the next 18-24 months after completing the technology transfer and would take part in the government's tender process for supply of the vaccine for eradication of FMD in India.

'Initially, we are targeting a production of about 5 million doses which will be increased by 25-30 per cent annually,' he said.

Asked if production of the FMD vaccine would require any investment from the company, he replied in the negative and said, 'this will be manufactured at our multi-product facility.' Jain said the company expected a significant contribution from the FMD vaccine to its overall topline and bottomline growth, but 'it is too early to quantify at the moment.' 'When we are near to about six months of production we should be able to finalise the pricing of the vaccine,' he added.

NRDC Chairman and Managing Director Somentah Ghosh said the organisation had also signed a similar in-licensing agreement with another Indian company but declined to disclose citing a confidentiality clause.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Panacea Biotech To Market Anthrax Vaccine
2. Panacea To Market Measles Vaccine In India
3. Websites That Offer Panacea for Eating Disorders may Be Dangerous
4. Biotechnology industry expected to grow into a three billion dollar industry by 2002
5. Biotechnology on the lead
6. Panacea Biotech To Market Anthrax Vaccine
7. Commercialization of Biotech Discoveries, An Encouragement For Researchers
8. Biotech drug causing anemia-EPREX
9. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
10. Biologicals Transfer Proposal between US and Indian Biotechnology
11. Vical Biotech and NIH jointly develops HIV vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, ... and around the greater Phoenix metropolitan region, is announcing a charity event to ... of the Homeless Youth Connection is to promote community awareness of the ongoing ...
(Date:12/8/2016)... ... , ... The Compretta Insurance Agency, a family owned insurance and financial consultation ... County area, is announcing the launch of a charity effort aimed at raising funds ... Pantry has worked for more than 30 years to meet the food needs of ...
(Date:12/8/2016)... ... 08, 2016 , ... Bill Mull Agencies, a Wichita-based firm ... around central Kansas, is joining the Youth Horizons organization for a charity event ... in Wichita, Youth Horizons works to empower area children from unstable, troubled, or ...
(Date:12/7/2016)... ... 07, 2016 , ... Students attending Envision’s summer 2017 ... get hands-on experience in an emergency medical simulation, When Care is Hours Away. ... real-life medical skills that are critical success in a future career and beyond. ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , 8 de dezembro de 2016  A Mederi Therapeutics Inc ... Stretta, um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and broadcast ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... Dec. 8, 2016 Bodycad announced it ... improving the accuracy, reproducibility and speed for 3D ... and small bone orthopaedic applications. These patents are ... personalized orthopaedic restorations based on each patient,s distinct ... the company harnesses the world,s first suite of ...
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
Breaking Medicine Technology: